Idiopathic Pleural Effusions: Characteristics and Discrimination From Cytology-Negative Malignant Pleural Effusions
- PMID: 32423747
- DOI: 10.1016/j.amjms.2020.04.020
Idiopathic Pleural Effusions: Characteristics and Discrimination From Cytology-Negative Malignant Pleural Effusions
Abstract
Background: The etiology of pleural effusions often remained unknown notwithstanding surgical pleural biopsy and further clinical observation. A better understanding of clinical characteristics of patients with idiopathic pleural effusion (IPE) may improve the ability to differentiate between IPEs and cytology-negative malignant pleural effusions (MPEs) and facilitate the identification of patients requiring invasive investigation. However, little is known about the clinical factors that can help distinguish patients with IPE from those with cytology-negative MPE.
Materials and methods: Patients who were diagnosed with IPE or cytology-negative MPE between 2010 and 2017 were enrolled in this retrospective study. Clinical, laboratory and radiologic characteristics were compared between patients with IPE and cytology-negative MPE. Diagnostic performances of predictors for IPE were assessed using receiver operating characteristic curves.
Results: Of 146 patients undergoing pleural biopsy owing to cytology-negative pleural effusion of uncertain cause, MPE was confirmed in 54 patients. IPE was ultimately diagnosed in 22 patients. Multivariate analysis demonstrated that a minimal amount of pleural effusion (odds ratio [OR] = 12.41, P = 0.039), presence of pleural nodularity (OR = 0.01, P < 0.001) and pleural fluid carcinoembryonic antigen levels less than 14 ng/mL (OR = 87.59, P = 0.002) were independent factors for distinguishing IPEs from cytology-negative MPEs. A combination of the absence of pleural nodularity with pleural fluid carcinoembryonic antigen levels less than 14 ng/mL yielded an area under the curve of 0.94 (sensitivity = 91% and specificity = 96%).
Conclusions: Using these readily available parameters to identify IPE in patients with cytology-negative exudative effusion of unknown cause can help guide decision-making when choosing to perform an invasive pleural biopsy or to take a conservative approach.
Keywords: Cytology-negative malignant pleural effusion; Idiopathic pleural effusion; Nonspecific pleuritis; Surgical thoracoscopic pleural biopsy.
Copyright © 2020 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.
Comment in
-
What Is the Next Step in a Patient With an Undiagnosed Exudative Pleural Effusion?Am J Med Sci. 2020 Sep;360(3):211-212. doi: 10.1016/j.amjms.2020.05.009. Epub 2020 May 13. Am J Med Sci. 2020. PMID: 32482349 No abstract available.
Similar articles
-
Laboratory Discrimination Between Neutrophilic Malignant and Parapneumonic Pleural Effusions.Am J Med Sci. 2019 Aug;358(2):115-120. doi: 10.1016/j.amjms.2019.04.009. Epub 2019 Apr 19. Am J Med Sci. 2019. PMID: 31331448
-
The value of exfoliative cell cytology in the diagnosis of exudative pleural effusions.Monaldi Arch Chest Dis. 2018 Sep 11;88(3):944. doi: 10.4081/monaldi.2018.944. Monaldi Arch Chest Dis. 2018. PMID: 30203633
-
Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.Chest. 2004 Dec;126(6):1757-63. doi: 10.1378/chest.126.6.1757. Chest. 2004. PMID: 15596670
-
Malignant pleural disease: a pragmatic guide to diagnosis.Curr Opin Pulm Med. 2022 Jul 1;28(4):282-287. doi: 10.1097/MCP.0000000000000877. Curr Opin Pulm Med. 2022. PMID: 35749791 Review.
-
Useful tests on the pleural fluid in the management of patients with pleural effusions.Curr Opin Pulm Med. 1999 Jul;5(4):245-9. doi: 10.1097/00063198-199907000-00012. Curr Opin Pulm Med. 1999. PMID: 10407695 Review.
Cited by
-
Evaluation of Exudative Pleural Effusions: A Multicenter, Prospective, Observational Study.Lung. 2022 Dec;200(6):807-815. doi: 10.1007/s00408-022-00573-8. Epub 2022 Sep 29. Lung. 2022. PMID: 36173482
MeSH terms
Substances
LinkOut - more resources
Full Text Sources